Coexpression cluster:C2558: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 12:08, 17 September 2013
Full id: C2558_CD14_Monocytederived_Macrophage_spleen_dura_lymph_left
Phase1 CAGE Peaks
Hg19::chr1:206944507..206944524,- | p3@IL10 |
Hg19::chr3:9142472..9142491,+ | p@chr3:9142472..9142491 + |
Hg19::chr5:36680430..36680455,+ | p6@SLC1A3 |
Hg19::chrX:5644225..5644242,- | p1@ENST00000422914 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0030886 | negative regulation of myeloid dendritic cell activation | 0.00373837277758154 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 0.00373837277758154 |
GO:0005141 | interleukin-10 receptor binding | 0.00373837277758154 |
GO:0032695 | negative regulation of interleukin-12 production | 0.00373837277758154 |
GO:0030885 | regulation of myeloid dendritic cell activation | 0.00421703056648373 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 0.00421703056648373 |
GO:0032655 | regulation of interleukin-12 production | 0.00421703056648373 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 0.00421703056648373 |
GO:0001773 | myeloid dendritic cell activation | 0.00421703056648373 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 0.00421703056648373 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 0.00421703056648373 |
GO:0045354 | regulation of interferon-alpha biosynthetic process | 0.00421703056648373 |
GO:0032607 | interferon-alpha production | 0.00421703056648373 |
GO:0045349 | interferon-alpha biosynthetic process | 0.00421703056648373 |
GO:0045342 | MHC class II biosynthetic process | 0.00421703056648373 |
GO:0045346 | regulation of MHC class II biosynthetic process | 0.00421703056648373 |
GO:0032615 | interleukin-12 production | 0.00421703056648373 |
GO:0007267 | cell-cell signaling | 0.00421703056648373 |
GO:0001504 | neurotransmitter uptake | 0.00421703056648373 |
GO:0032606 | interferon type I production | 0.00421703056648373 |
GO:0042130 | negative regulation of T cell proliferation | 0.00421703056648373 |
GO:0005313 | L-glutamate transmembrane transporter activity | 0.00421703056648373 |
GO:0045351 | interferon type I biosynthetic process | 0.00421703056648373 |
GO:0045191 | regulation of isotype switching | 0.00421703056648373 |
GO:0015172 | acidic amino acid transmembrane transporter activity | 0.00421703056648373 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 0.00421703056648373 |
GO:0002237 | response to molecule of bacterial origin | 0.00421703056648373 |
GO:0042092 | T-helper 2 type immune response | 0.00421703056648373 |
GO:0001818 | negative regulation of cytokine production | 0.00421703056648373 |
GO:0051220 | cytoplasmic sequestering of protein | 0.00421703056648373 |
GO:0042308 | negative regulation of protein import into nucleus | 0.00421703056648373 |
GO:0002208 | somatic diversification of immunoglobulins during immune response | 0.00421703056648373 |
GO:0002381 | immunoglobulin production during immune response | 0.00421703056648373 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 0.00421703056648373 |
GO:0050672 | negative regulation of lymphocyte proliferation | 0.00421703056648373 |
GO:0002204 | somatic recombination of immunoglobulin genes during immune response | 0.00421703056648373 |
GO:0050868 | negative regulation of T cell activation | 0.00421703056648373 |
GO:0045190 | isotype switching | 0.00421703056648373 |
GO:0032945 | negative regulation of mononuclear cell proliferation | 0.00421703056648373 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 0.00422524021915686 |
GO:0042348 | NF-kappaB import into nucleus | 0.00422524021915686 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 0.00422524021915686 |
GO:0015813 | L-glutamate transport | 0.00422524021915686 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 0.00422524021915686 |
GO:0051224 | negative regulation of protein transport | 0.00422524021915686 |
GO:0015800 | acidic amino acid transport | 0.00422524021915686 |
GO:0016444 | somatic cell DNA recombination | 0.00448512294667026 |
GO:0016445 | somatic diversification of immunoglobulins | 0.00448512294667026 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 0.00448512294667026 |
GO:0017153 | sodium:dicarboxylate symporter activity | 0.00448512294667026 |
GO:0002200 | somatic diversification of immune receptors | 0.00460005837853158 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 0.00460005837853158 |
GO:0006835 | dicarboxylic acid transport | 0.00470647192314367 |
GO:0005310 | dicarboxylic acid transmembrane transporter activity | 0.00470647192314367 |
GO:0002377 | immunoglobulin production | 0.00480527663985466 |
GO:0042100 | B cell proliferation | 0.00480527663985466 |
GO:0051250 | negative regulation of lymphocyte activation | 0.00498317648473598 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.00532086228261171 |
GO:0042991 | transcription factor import into nucleus | 0.00532086228261171 |
GO:0042306 | regulation of protein import into nucleus | 0.00539139544131378 |
GO:0033157 | regulation of intracellular protein transport | 0.00539139544131378 |
GO:0030595 | leukocyte chemotaxis | 0.00554546659648675 |
GO:0032507 | maintenance of cellular protein localization | 0.0056622003417305 |
GO:0050864 | regulation of B cell activation | 0.0056622003417305 |
GO:0051651 | maintenance of cellular localization | 0.0056622003417305 |
GO:0032386 | regulation of intracellular transport | 0.0056622003417305 |
GO:0045185 | maintenance of protein localization | 0.00580071207558523 |
GO:0002440 | production of molecular mediator of immune response | 0.00584912688971298 |
GO:0002274 | myeloid leukocyte activation | 0.00584912688971298 |
GO:0051223 | regulation of protein transport | 0.00597901945045953 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.00602045177069617 |
GO:0030183 | B cell differentiation | 0.00602045177069617 |
GO:0051051 | negative regulation of transport | 0.00626153430883787 |
GO:0050900 | leukocyte migration | 0.00626153430883787 |
GO:0015179 | L-amino acid transmembrane transporter activity | 0.00637724512346562 |
GO:0042129 | regulation of T cell proliferation | 0.00668647045420683 |
GO:0005343 | organic acid:sodium symporter activity | 0.00737562614066439 |
GO:0015296 | anion:cation symporter activity | 0.00737797439175931 |
GO:0042098 | T cell proliferation | 0.00737797439175931 |
GO:0001817 | regulation of cytokine production | 0.00747223366902842 |
GO:0051235 | maintenance of localization | 0.00747223366902842 |
GO:0017148 | negative regulation of translation | 0.00747223366902842 |
GO:0050670 | regulation of lymphocyte proliferation | 0.00747223366902842 |
GO:0032944 | regulation of mononuclear cell proliferation | 0.00747223366902842 |
GO:0031327 | negative regulation of cellular biosynthetic process | 0.00791142726813731 |
GO:0009890 | negative regulation of biosynthetic process | 0.00870251049755147 |
GO:0016064 | immunoglobulin mediated immune response | 0.00870251049755147 |
GO:0019724 | B cell mediated immunity | 0.00870251049755147 |
GO:0032943 | mononuclear cell proliferation | 0.00870251049755147 |
GO:0045727 | positive regulation of translation | 0.00870251049755147 |
GO:0046651 | lymphocyte proliferation | 0.00870251049755147 |
GO:0005126 | hematopoietin/interferon-class (D200-domain) cytokine receptor binding | 0.00943610885175068 |
GO:0050863 | regulation of T cell activation | 0.00943610885175068 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.00943610885175068 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.00943610885175068 |
GO:0042113 | B cell activation | 0.00949330646860266 |
GO:0015171 | amino acid transmembrane transporter activity | 0.0097031985626071 |
GO:0030098 | lymphocyte differentiation | 0.00975649000092232 |
GO:0042089 | cytokine biosynthetic process | 0.0101102086620081 |
GO:0042107 | cytokine metabolic process | 0.0101583465632025 |
GO:0006865 | amino acid transport | 0.0102517777777559 |
GO:0009891 | positive regulation of biosynthetic process | 0.0102517777777559 |
GO:0002449 | lymphocyte mediated immunity | 0.0104420024233583 |
GO:0002250 | adaptive immune response | 0.0106885360918715 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0106885360918715 |
GO:0051249 | regulation of lymphocyte activation | 0.0106885360918715 |
GO:0006836 | neurotransmitter transport | 0.0106885360918715 |
GO:0002443 | leukocyte mediated immunity | 0.0106885360918715 |
GO:0001505 | regulation of neurotransmitter levels | 0.0106885360918715 |
GO:0050865 | regulation of cell activation | 0.0108626209758598 |
GO:0015837 | amine transport | 0.0113023312774558 |
GO:0051247 | positive regulation of protein metabolic process | 0.0113346007808109 |
GO:0015370 | solute:sodium symporter activity | 0.0116302848965169 |
GO:0002521 | leukocyte differentiation | 0.0117899233592696 |
GO:0042742 | defense response to bacterium | 0.0121168876006111 |
GO:0006606 | protein import into nucleus | 0.0121168876006111 |
GO:0046943 | carboxylic acid transmembrane transporter activity | 0.0121168876006111 |
GO:0046942 | carboxylic acid transport | 0.0121168876006111 |
GO:0051170 | nuclear import | 0.0121168876006111 |
GO:0042110 | T cell activation | 0.0121168876006111 |
GO:0015849 | organic acid transport | 0.0121168876006111 |
GO:0005342 | organic acid transmembrane transporter activity | 0.0121168876006111 |
GO:0051248 | negative regulation of protein metabolic process | 0.0126244345520289 |
GO:0009617 | response to bacterium | 0.0127630680133989 |
GO:0002252 | immune effector process | 0.0130336914204533 |
GO:0051049 | regulation of transport | 0.0130336914204533 |
GO:0001816 | cytokine production | 0.0132831418191474 |
GO:0015294 | solute:cation symporter activity | 0.0132958028230356 |
GO:0017038 | protein import | 0.0141168753275877 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 0.0159562573805025 |
GO:0042330 | taxis | 0.0162785650400583 |
GO:0006935 | chemotaxis | 0.0162785650400583 |
GO:0006913 | nucleocytoplasmic transport | 0.0172401688036447 |
GO:0046649 | lymphocyte activation | 0.0172401688036447 |
GO:0051169 | nuclear transport | 0.0172401688036447 |
GO:0030097 | hemopoiesis | 0.0176606066078919 |
GO:0006916 | anti-apoptosis | 0.0185092718642826 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.0186985862633258 |
GO:0045321 | leukocyte activation | 0.0192502490155955 |
GO:0007626 | locomotory behavior | 0.0192502490155955 |
GO:0002520 | immune system development | 0.0192502490155955 |
GO:0006417 | regulation of translation | 0.0193241649736255 |
GO:0006310 | DNA recombination | 0.0205408360571791 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0206046712896671 |
GO:0051707 | response to other organism | 0.0211801702295847 |
GO:0001775 | cell activation | 0.0211953183833238 |
GO:0008509 | anion transmembrane transporter activity | 0.0211953183833238 |
GO:0032501 | multicellular organismal process | 0.021662995930589 |
GO:0009889 | regulation of biosynthetic process | 0.021662995930589 |
GO:0006605 | protein targeting | 0.021662995930589 |
GO:0008285 | negative regulation of cell proliferation | 0.0222082308787569 |
GO:0043066 | negative regulation of apoptosis | 0.0222575744863357 |
GO:0043069 | negative regulation of programmed cell death | 0.0224033379698629 |
GO:0016477 | cell migration | 0.0225471826960967 |
GO:0006810 | transport | 0.023112770376829 |
GO:0015293 | symporter activity | 0.0231147989916142 |
GO:0051234 | establishment of localization | 0.023855702942669 |
GO:0008083 | growth factor activity | 0.023855702942669 |
GO:0051239 | regulation of multicellular organismal process | 0.0259452236696486 |
GO:0009607 | response to biotic stimulus | 0.0267462490658675 |
GO:0007268 | synaptic transmission | 0.0267462490658675 |
GO:0006954 | inflammatory response | 0.0267462490658675 |
GO:0007610 | behavior | 0.0268550136245768 |
GO:0051179 | localization | 0.0269409793953437 |
GO:0005125 | cytokine activity | 0.0279666644296476 |
GO:0019226 | transmission of nerve impulse | 0.0295828715497254 |
GO:0051704 | multi-organism process | 0.029671736813535 |
GO:0015291 | secondary active transmembrane transporter activity | 0.0318738815999311 |
GO:0031325 | positive regulation of cellular metabolic process | 0.0321229753329957 |
GO:0007243 | protein kinase cascade | 0.0328910569679788 |
GO:0031324 | negative regulation of cellular metabolic process | 0.0329189960355018 |
GO:0006928 | cell motility | 0.0329189960355018 |
GO:0051674 | localization of cell | 0.0329189960355018 |
GO:0009893 | positive regulation of metabolic process | 0.0334095011152632 |
GO:0051246 | regulation of protein metabolic process | 0.0357161306587689 |
GO:0009611 | response to wounding | 0.0357161306587689 |
GO:0009892 | negative regulation of metabolic process | 0.0365987540911655 |
GO:0007154 | cell communication | 0.0382169243973137 |
GO:0042127 | regulation of cell proliferation | 0.0389099379666876 |
GO:0005615 | extracellular space | 0.0433642124796889 |
GO:0006886 | intracellular protein transport | 0.0433642124796889 |
GO:0050789 | regulation of biological process | 0.0455825782743777 |
GO:0042981 | regulation of apoptosis | 0.0461863797398652 |
GO:0043067 | regulation of programmed cell death | 0.0464147630813704 |
GO:0006952 | defense response | 0.0467994791501073 |
GO:0042221 | response to chemical stimulus | 0.0469429105331343 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
monopoietic cell | 6.14e-56 | 59 |
monocyte | 6.14e-56 | 59 |
monoblast | 6.14e-56 | 59 |
promonocyte | 6.14e-56 | 59 |
macrophage dendritic cell progenitor | 1.28e-53 | 61 |
defensive cell | 1.34e-53 | 48 |
phagocyte | 1.34e-53 | 48 |
myeloid lineage restricted progenitor cell | 1.94e-48 | 66 |
granulocyte monocyte progenitor cell | 1.70e-47 | 67 |
myeloid leukocyte | 2.68e-45 | 72 |
classical monocyte | 3.82e-43 | 42 |
CD14-positive, CD16-negative classical monocyte | 3.82e-43 | 42 |
myeloid cell | 1.94e-26 | 108 |
common myeloid progenitor | 1.94e-26 | 108 |
stuff accumulating cell | 1.50e-23 | 87 |
nongranular leukocyte | 9.13e-23 | 115 |
hematopoietic lineage restricted progenitor cell | 3.92e-20 | 120 |
leukocyte | 5.53e-19 | 136 |
hematopoietic oligopotent progenitor cell | 4.41e-13 | 161 |
hematopoietic multipotent progenitor cell | 4.41e-13 | 161 |
hematopoietic stem cell | 1.05e-12 | 168 |
angioblastic mesenchymal cell | 1.05e-12 | 168 |
macrophage | 3.30e-12 | 6 |
hematopoietic cell | 2.20e-11 | 177 |
adult endothelial progenitor cell | 3.42e-07 | 3 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.0938548 |
MA0004.1 | 0.71247 |
MA0006.1 | 0.532262 |
MA0007.1 | 2.78189 |
MA0009.1 | 1.20602 |
MA0014.1 | 0.244769 |
MA0017.1 | 0.577281 |
MA0019.1 | 0.873355 |
MA0024.1 | 1.09684 |
MA0025.1 | 1.34373 |
MA0027.1 | 2.83281 |
MA0028.1 | 0.550763 |
MA0029.1 | 1.11704 |
MA0030.1 | 1.10506 |
MA0031.1 | 1.03735 |
MA0038.1 | 0.824639 |
MA0040.1 | 1.12314 |
MA0041.1 | 0.732902 |
MA0042.1 | 0.697662 |
MA0043.1 | 1.20635 |
MA0046.1 | 1.19471 |
MA0048.1 | 0.25531 |
MA0050.1 | 0.69864 |
MA0051.1 | 0.820063 |
MA0052.1 | 1.12718 |
MA0055.1 | 0.396851 |
MA0056.1 | 0 |
MA0057.1 | 0.248209 |
MA0058.1 | 0.605914 |
MA0059.1 | 0.604454 |
MA0060.1 | 0.393285 |
MA0061.1 | 0.360128 |
MA0063.1 | 0 |
MA0066.1 | 0.825101 |
MA0067.1 | 1.53181 |
MA0068.1 | 0.313194 |
MA0069.1 | 1.19071 |
MA0070.1 | 1.17908 |
MA0071.1 | 0.782546 |
MA0072.1 | 1.1744 |
MA0073.1 | 0.100363 |
MA0074.1 | 0.819248 |
MA0076.1 | 0.623864 |
MA0077.1 | 1.16637 |
MA0078.1 | 0.926725 |
MA0081.1 | 0.604638 |
MA0083.1 | 1.21381 |
MA0084.1 | 1.72172 |
MA0087.1 | 1.17185 |
MA0088.1 | 0.182167 |
MA0089.1 | 0 |
MA0090.1 | 0.640115 |
MA0091.1 | 0.715356 |
MA0092.1 | 0.673508 |
MA0093.1 | 0.535768 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.83965 |
MA0101.1 | 0.539569 |
MA0103.1 | 0.521546 |
MA0105.1 | 0.232357 |
MA0106.1 | 0.869173 |
MA0107.1 | 0.453492 |
MA0108.2 | 1.03412 |
MA0109.1 | 0 |
MA0111.1 | 0.655276 |
MA0113.1 | 2.05499 |
MA0114.1 | 0.447443 |
MA0115.1 | 1.45393 |
MA0116.1 | 0.457606 |
MA0117.1 | 1.24497 |
MA0119.1 | 0.586221 |
MA0122.1 | 1.27173 |
MA0124.1 | 1.41151 |
MA0125.1 | 1.32534 |
MA0130.1 | 0 |
MA0131.1 | 0.94608 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.23748 |
MA0136.1 | 0.832277 |
MA0139.1 | 0.344952 |
MA0140.1 | 0.779643 |
MA0141.1 | 0.602484 |
MA0142.1 | 1.00381 |
MA0143.1 | 0.887001 |
MA0144.1 | 0.430413 |
MA0145.1 | 0.195821 |
MA0146.1 | 0.061409 |
MA0147.1 | 0.46175 |
MA0148.1 | 0.739888 |
MA0149.1 | 0.769072 |
MA0062.2 | 0.353589 |
MA0035.2 | 0.778873 |
MA0039.2 | 0.10559 |
MA0138.2 | 0.928035 |
MA0002.2 | 0.379056 |
MA0137.2 | 0.558189 |
MA0104.2 | 0.392359 |
MA0047.2 | 0.856092 |
MA0112.2 | 0.551048 |
MA0065.2 | 0.199162 |
MA0150.1 | 0.633493 |
MA0151.1 | 0 |
MA0152.1 | 0.78681 |
MA0153.1 | 1.30799 |
MA0154.1 | 0.229241 |
MA0155.1 | 0.180766 |
MA0156.1 | 0.560797 |
MA0157.1 | 0.97481 |
MA0158.1 | 0 |
MA0159.1 | 0.462502 |
MA0160.1 | 0.756582 |
MA0161.1 | 0 |
MA0162.1 | 0.0928415 |
MA0163.1 | 0.0725493 |
MA0164.1 | 0.90014 |
MA0080.2 | 0.535868 |
MA0018.2 | 0.870662 |
MA0099.2 | 0.7872 |
MA0079.2 | 0.0270533 |
MA0102.2 | 1.75932 |
MA0258.1 | 0.418966 |
MA0259.1 | 0.471671 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.